According to research reviewed by Gram, a randomized controlled trial of 244 healthy newborns in Papua New Guinea found that probiotic supplementation is safe and feasible, with 89% of babies completing the full 7-day treatment course without safety concerns, demonstrating viability even in resource-limited settings.
Researchers in Papua New Guinea tested whether giving healthy bacteria supplements (probiotics) to newborn babies is safe and practical. They gave 244 healthy newborns either probiotics or a fake treatment for one week, then followed them for six months. The study found that giving probiotics to newborns is safe and doable, even in a developing country with limited resources. Most babies (89%) completed the full week of treatment, and researchers successfully collected samples to study how the probiotics affected the babies’ health, immune systems, and gut bacteria.
Key Statistics
In a randomized controlled trial of 244 healthy newborns in Papua New Guinea, 89.3% completed the full 7-day probiotic treatment course without any safety issues.
Researchers achieved over 98% sample collection rates for saliva, blood, and swab samples across multiple time points in the probiotic feasibility study of 244 newborns.
A 2024 study of 244 newborns in Papua New Guinea demonstrated that 69.3% of participants completed the full six-month follow-up period despite COVID-19 disruptions affecting 31% of the cohort.
The Quick Take
- What they studied: Whether giving probiotic supplements to healthy newborn babies is safe and practical in Papua New Guinea
- Who participated: 244 healthy newborn babies less than 3 days old from the Eastern Highlands Province of Papua New Guinea
- Key finding: 89% of babies completed the full 7-day probiotic treatment with no safety concerns, showing it’s both safe and doable
- What it means for you: This suggests probiotics may be a safe way to help protect newborns from infections, but more research is needed before recommending routine use
The Research Details
This was a randomized controlled trial, which is considered the gold standard for testing medical treatments. Researchers randomly divided 244 healthy newborns into three equal groups. One group got probiotics containing Lactiplantibacillus plantarum, another got probiotics with Bifidobacterium longum, and the third got a placebo (fake treatment). Neither parents nor researchers knew which treatment each baby received, preventing bias in the results. The babies took their assigned treatment daily for one week, then researchers followed them for six months to track their health and development.
This study design is important because it eliminates bias and allows researchers to directly compare the effects of different probiotic strains against no treatment. The double-blind approach means expectations couldn’t influence the results.
The study achieved very high sample collection rates (over 98% for most tests) and was conducted according to strict ethical guidelines. However, COVID-19 disruptions meant about 31% of babies couldn’t complete the full six-month follow-up period.
What the Results Show
The study successfully demonstrated that giving probiotics to newborns in Papua New Guinea is both feasible and safe. Of the 244 babies enrolled, 218 (89.3%) completed the full 7-day treatment course without any safety issues. Researchers were able to collect samples at extremely high rates - nearly 100% success for saliva, blood, and swab samples at multiple time points. This shows that even in a resource-limited setting, probiotic supplementation can be implemented effectively. The COVID-19 pandemic created unexpected challenges, with some families having to relocate outside the study area, but this didn’t affect the safety findings.
While 69.3% of babies completed the full six-month study period, the high sample collection rates mean researchers gathered substantial data about how probiotics affect gut bacteria, immune responses to vaccines, and infection rates. The study also provided valuable insights into conducting clinical trials in low- and middle-income countries during global health emergencies.
Previous research has shown probiotics can help reduce infections and deaths in premature babies, but this is one of the first studies to specifically test probiotics in healthy, full-term newborns in a developing country setting.
The main limitation was that COVID-19 disruptions prevented about 31% of participants from completing the full study. The researchers are still analyzing the data, so the actual health benefits of the probiotics haven’t been reported yet. This study focused on safety and feasibility rather than measuring specific health improvements.
The Bottom Line
Based on this study, probiotic supplementation appears safe for healthy newborns, but parents should wait for the complete results before considering probiotics for their babies. The full analysis expected by end of 2025 will reveal whether the probiotics actually improved health outcomes.
Parents of newborns, especially those in developing countries where infant infections are common, should follow this research. Healthcare providers working in low-resource settings may also find these feasibility insights valuable.
The complete results showing whether probiotics actually prevent infections and improve health will be available by the end of 2025. If positive, larger studies would likely take several more years before probiotics become routine care.
Frequently Asked Questions
Is it safe to give probiotics to healthy newborn babies?
Gram Research analysis shows that in a study of 244 healthy newborns, 89% completed probiotic treatment with no safety concerns, suggesting probiotics are safe for newborns. However, complete health outcome data won’t be available until end of 2025.
Can probiotic studies be conducted in developing countries?
Yes. A Papua New Guinea trial of 244 newborns achieved over 98% sample collection rates, demonstrating that probiotic research is feasible in resource-limited settings, though COVID-19 disruptions affected 31% of six-month follow-ups.
What do we know about probiotics preventing infections in newborns?
Previous research shows probiotics reduce infections in premature babies, but this Papua New Guinea study of 244 healthy full-term newborns is one of the first testing this in developing countries. Complete infection prevention data is expected by end of 2025.
Should I give my newborn probiotics right now?
Parents should wait for complete results expected by end of 2025 before considering probiotics. Consult your pediatrician first. Current evidence shows safety but not yet proven health benefits for healthy newborns.
Want to Apply This Research?
- Track infant feeding patterns, illness episodes, and antibiotic use during the first six months of life
- Focus on established newborn health practices like breastfeeding and proper hygiene while waiting for complete probiotic research results
- Monitor infant growth, feeding tolerance, and any signs of digestive issues or infections over the first six months
This research is still ongoing and complete results are not yet available. Do not give probiotics to infants without consulting your pediatrician. This information is for educational purposes only and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.